title: 2D solid-state NMR analysis of inclusion in drug-cyclodextrin complexes.
abstract: The solubility of drug molecules can often be improved through preparation and delivery of cyclodextrin (CD) inclusion complexes. These drug-oligosaccharide complexes can be prepared in solution and converted to the solid state via methods such as lyophilization and spray-drying, or they can be prepared directly from solids by a variety of methods. The development of drug-CD complexes as solids allows for potential advantages in dosage form design, such as the preparation of layered formulations, and it also can yield improvements in chemical and physical stability. 2D solid-state NMR (SSNMR) methods provide a direct way to probe drug-CD interactions in solid complexes through dipolar interactions between nuclei within the drug and CD molecules. In this study, 2D heteronuclear and homonuclear correlation SSNMR experiments involving (1)H, (13)C, (19)F, and (31)P nuclei are used to demonstrate the inclusion of drug within the CD cavity in a variety of powder samples. To illustrate the general applicability of the SSNMR approach presented, examples are shown for the drugs diflunisal, adefovir dipivoxil, voriconazole, dexamethasone, and prednisolone in complexes with α-CD, β-CD, and sulfobutylether-substituted β-CD. The quantitative analysis of included and free drug fractions in a solid drug-CD complex using SSNMR is also demonstrated. On the basis of these results, general approaches to the characterization of these materials using SSNMR are proposed.
authors.affiliation: Product Development, GlaxoSmithKline plc, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States. Fred.G.Vogt@gsk.com
authors.forename: Frederick G
authors.initials: FG
authors.lastname: Vogt
authors.forename: Mark
authors.initials: M
authors.lastname: Strohmeier
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D002250:Carbon Radioisotopes; D003505:Cyclodextrins / Q000737:chemistry* / Q000378:metabolism; D004061:Diflunisal / Q000737:chemistry* / Q000378:metabolism; D005462:Fluorine Radioisotopes; D006859:Hydrogen / Q000737:chemistry; D015394:Molecular Structure; D019906:Nuclear Magnetic Resonance, Biomolecular; D063065:Organophosphonates / Q000737:chemistry* / Q000378:metabolism; D010758:Phosphorus / Q000737:chemistry; D011743:Pyrimidines / Q000737:chemistry* / Q000378:metabolism; D014230:Triazoles / Q000737:chemistry* / Q000378:metabolism; D065819:Voriconazole
chemical_list: D002250:Carbon Radioisotopes; D003505:Cyclodextrins; D005462:Fluorine Radioisotopes; D063065:Organophosphonates; D011743:Pyrimidines; D014230:Triazoles; D010758:Phosphorus; D004061:Diflunisal; D006859:Hydrogen; D000225:Adenine; D065819:Voriconazole; C106812:adefovir dipivoxil